Shteinberg M - Search Results

1

Unravelling the "frequent exacerbator" phenotype in cystic fibrosis.

Cohen R, Shteinberg M. Cohen R, et al. Among authors: shteinberg m. Eur Respir J. 2024 Feb 22;63(2):2400068. doi: 10.1183/13993003.00068-2024. Print 2024 Feb. Eur Respir J. 2024. PMID: 38388000 No abstract available.

2

[BRONCHIECTASIS--REVIEW OF LITERATURE AND CLINICAL CHARACTERISTICS OF BRONCHIECTASIS PATIENTS TREATED IN THE BRONCHIECTASIS CLINIC AT THE CARMEL MEDICAL CENTER].

Shteinberg M, Yaari N, Stein N, Amital A, Israeli D, Adir Y. Shteinberg M, et al. Harefuah. 2015 Jun;154(6):356-61, 406, 405. Harefuah. 2015. PMID: 26281077 Review. Hebrew.

3

The EMBARC European Bronchiectasis Registry: protocol for an international observational study.

Chalmers JD, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M, Dimakou K, Clifton I, van der Eerden M, Rohde G, Murris-Espin M, Masefield S, Gerada E, Shteinberg M, Ringshausen F, Haworth C, Boersma W, Rademacher J, Hill AT, Aksamit T, O'Donnell A, Morgan L, Milenkovic B, Tramma L, Neves J, Menendez R, Paggiaro P, Botnaru V, Skrgat S, Wilson R, Goeminne P, De Soyza A, Welte T, Torres A, Elborn JS, Blasi F. Chalmers JD, et al. Among authors: shteinberg m. ERJ Open Res. 2016 Jan 20;2(1):00081-2015. doi: 10.1183/23120541.00081-2015. eCollection 2016 Jan. ERJ Open Res. 2016. PMID: 27730179 Free PMC article.

4

[CYSTIC FIBROSIS SURVIVAL TRENDS IN CARMEL MEDICAL CENTER].

Nathan K, Shteinberg M, Rivlin J. Nathan K, et al. Among authors: shteinberg m. Harefuah. 2015 Jun;154(6):373-6, 404. Harefuah. 2015. PMID: 26281081 Hebrew.

5

Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.

De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdood P, Hooghe R, Hooghe-Peters E. De Schepper J, et al. Among authors: shteinberg m. Eur J Endocrinol. 2003 Sep;149(3):201-7. doi: 10.1530/eje.0.1490201. Eur J Endocrinol. 2003. PMID: 12943522

6

[Central alveolar hypoventilation in adults--Ondine's curse].

Shteinberg M, Edoute Y. Shteinberg M, et al. Harefuah. 2000 Feb 1;138(3):234-6. Harefuah. 2000. PMID: 10883100 Review. Hebrew. No abstract available.

7

Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey.

Shteinberg M, Stein N, Adir Y, Ken-Dror S, Shitrit D, Bendayan D, Fuks L, Saliba W. Shteinberg M, et al. Eur Respir J. 2018 May 10;51(5):1702469. doi: 10.1183/13993003.02469-2017. Print 2018 May. Eur Respir J. 2018. PMID: 29545278 Free article. No abstract available.

8

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD. Polverino E, et al. Among authors: shteinberg m. Eur Respir J. 2018 Sep 15;52(3):1800328. doi: 10.1183/13993003.00328-2018. Print 2018 Sep. Eur Respir J. 2018. PMID: 30049739 Free article. Review.

9

New insights into immunological responses to infection in bronchiectasis.

Shteinberg M, Shah A, Elborn JS. Shteinberg M, et al. Eur Respir J. 2019 Feb 7;53(2):1802395. doi: 10.1183/13993003.02395-2018. Print 2019 Feb. Eur Respir J. 2019. PMID: 30759421 Free article. No abstract available.

10

Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease.

Shteinberg M, Taylor-Cousar JL. Shteinberg M, et al. Eur Respir Rev. 2020 Mar 20;29(155):190112. doi: 10.1183/16000617.0112-2019. Print 2020 Mar 31. Eur Respir Rev. 2020. PMID: 32198216 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters